Table 2.
Association of screening instruments with mortality of older hospitalized COVID-19 patients
| In-hospital mortality | 30-days-mortality | |||||
|---|---|---|---|---|---|---|
| Variable | n = /N = | OR (95% CI) | p-value | n = /N = | OR (95% CI) | p-value |
| APOP | ||||||
| Low risk | 47/251 | Ref | 55/251 | Ref | ||
| High riska | 37/138 | 1.59 (0.97–2.60) | 0.065 | 59/138 | 2.66 (1.70–4.18) | < 0.001 |
| CFS | ||||||
| Low | 24/161 | Ref | 28/161 | Ref | ||
| Highb | 47/186 | 1.93 (1.12–3.30) | 0.018 | 70/186 | 2.87 (1.73–4.75) | < 0.001 |
| Agec | 84/389 | 1.02 (0.99–1.06) | 0.220 | 114/389 | 1.06 (1.03–1.10) | < 0.001 |
n number of deceased patients, N total number of cases without missing values, Analysis binary univariate logistic regression analysis, Missing 42 CFS, N number
a45% and more risk for mortality or functional decline on APOP screener
bCFS ≥ 4
cContinuous per year